Pharmaxis Ltd (SNT) Gets a Buy from Bell Potter
Bell Potter analyst Thomas Wakim maintained a Buy rating on Pharmaxis Ltd (SNT – Research Report) today and set a price target of A$0.12. The company's shares closed last Friday at A$0.07.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Wakim is an analyst with an average return of -11.0% and a 30.30% success rate. Wakim covers the Healthcare sector, focusing on stocks such as Neuren Pharmaceuticals Limited, MedAdvisor Limited, and Alcidion Group Limited.
Pharmaxis Ltd has an analyst consensus of Moderate Buy, with a price target consensus of A$0.27, which is a 302.99% upside from current levels. In a report released yesterday, Canaccord Genuity also maintained a Buy rating on the stock with a A$0.27 price target.
The company has a one-year high of A$0.10 and a one-year low of A$0.02. Currently, Pharmaxis Ltd has an average volume of 8.46M.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Couchbase downgraded to Hold from Buy at Truist
Truist downgraded Couchbase (BASE) to Hold from Buy with a price target of $24.50, up from $21, after the company announced an agreement to be acquired by Haveli Investments for $24.50 per share in cash. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Business Insider
an hour ago
- Business Insider
Trade Desk management to meet virtually with Benchmark
Virtual Meeting to be held on June 26 at 11 am hosted by Benchmark. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Business Insider
an hour ago
- Business Insider
Lavoro downgraded to Hold from Buy at Canaccord
Canaccord downgraded Lavoro (LVRO) to Hold from Buy with a price target of $2.25, down from $5.50. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
